Lupin Limited sees explosive profit surge in Q1 FY2025
Lupin Limited has reported a remarkable financial performance for the quarter ending June 30, 2024. The pharmaceutical giant's sales for Q1 FY2025 reached INR 55,143 ... Read More
Zydus and Lupin forge alliance for NAFLD and NASH treatment in India
In a significant move within the pharmaceutical industry, Zydus Lifesciences Limited, renowned for its global lifesciences innovations, and Lupin Limited, a leading global pharma entity, ... Read More
Lupin’s Nagpur Unit-1 gets FDA nod with VAI status
Global pharmaceutical powerhouse, Lupin Limited has announced the receipt of the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) ... Read More
Lupin acquires five legacy brands, intensifies Indian pharma dominance
In a move that has set the pharmaceutical industry abuzz, global pharma titan Lupin Limited has revealed the acquisition of five key legacy brands, zeroing ... Read More
Lupin acquires diabetes brands ONDERO and ONDERO MET from Boehringer Ingelheim
In a strategic move to fortify its position in the pharmaceutical domain, global major Lupin Limited proclaimed its acquisition of coveted diabetes brands ONDERO and ... Read More
Lupin Limited continues momentum in Q1 FY2024: Insights into earnings and sales
Pharmaceutical giant Lupin Limited reported its Q1 FY2024 financial performance, indicating a gross profit of INR 31,013 million, up from INR 25,803 million in Q4 ... Read More
FDA concludes inspection at Lupin Bioresearch Centre in Pune
Lupin said that the US Food and Drug Administration (FDA) has concluded an inspection of the company’s bioresearch centre in Pune, Maharashtra. The inspection was ... Read More
Lupin reports completion of FDA inspection at Vizag plant with no observations
Lupin said that the US Food and Drug Administration (FDA) has wrapped up a pre-approval and GMP inspection of its API manufacturing plant in Visakhapatnam, ... Read More
Shahin Fesharaki appointed as Lupin Global Chief Scientific Officer
Indian pharmaceutical company Lupin announced that Dr. Shahin Fesharaki has been appointed as Global Chief Scientific Officer who will handle global research and development works ... Read More
Lupin partners with procurement agencies for TB prevention treatment
Lupin Limited has entered into partnerships with Unitaid, the Clinton Health Access Initiative (CHAI), The Aurum Institute, and other global procurement agencies for supporting tuberculosis ... Read More